Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Isoalantolactone promotes hair growth by activating specific cell pathways.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The supplement may improve hair growth and quality in women with mild to moderate hair loss.

Finasteride reduces hair growth and is safe for women with excessive hair.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

A woman with severe angioedema improved significantly after treatment with rituximab.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Equol may help with antiaging and skin health by boosting collagen and blocking certain hormones.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.